Background: False-positive cardiac troponin (Tn) results caused by outliers have been reported on various analytical platforms. We have compared the precision profile and outlier rate of the Abbott Diagnostics contemporary troponin I (TnI) assay with their high sensitivity (hs) TnI assay. Methods: Three studies were conducted over a 10-month period using routine patients' samples. TnI was measured in duplicate using the contemporary TnI assay in Study 1 and Study 2 (n ¼ 7011 and 7089) and the hs-TnI assay in Study 3 (n ¼ 1522). Critical outliers were defined as duplicate results whose absolute difference exceeded a critical difference (CD ¼ z xˇ2 x SD Analytical ) at a probability level of 0.0005, with one of the results on the opposite side of the decision limit to its partner. Results: The TnI concentration at 10% imprecision (coefficient of variation) for the contemporary TnI assay was 0.034 mg/L (Study 1) and 0.042 mg/L (Study 2), and 0.006 mg/L (6 ng/L) for the hs-TnI assay. The critical outlier rates for the contemporary TnI assay were 0.51% (Study 1) and 0.37% (Study 2) using a cut-off of 0.04 mg/L, and 0% for the hs-TnI assay using gender-specific cut-offs. Conclusion: The significant number of critical outliers detected using the contemporary TnI assay may pose a risk for misclassification of patients. By contrast, no critical outliers were detected using the hs-TnI assay. However, the total outlier rates for both assays were significantly higher than the expected variability of either assay. The cause of these outliers remains unclear.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.